SFCRI’s Current Studies

We invite you to find out if you may be able to take part in a study for women who experience moderate-to-severe pain associated with endometriosis. Eligible participants will receive all study-related care, investigational medication, and non-hormonal birth control supplies (as applicable) at no cost.

This clinical study will research the safety and effectiveness of an investigational birth control pill to prevent pregnancy in adult women with uterine fibroids or endometriosis

This clinical trial is designed to study how an experimental medication affects the health of adults living with obesity. Obesity is a critical health issue, and finding treatments that can help people lose weight could significantly improve the well-being of those affected. The study’s primary goal is to understand whether the investigational medication is safe and effective in reducing the impact of obesity and its related health problems. With this research, we hope to discover new ways to manage obesity and its health consequences.

This clinical study looks to determine if an investigational drug is safe and effective for adults with type 2 diabetes compared to conventional treatment options. The researchers aim to show how well the drug controls blood sugar levels while reducing participants’ body weight and waist size. The trial seeks valuable insights into the drug’s potential as a new and improved treatment option for individuals with type 2 diabetes.

This clinical trial examines a once-daily oral treatment for overweight and obese adult patients with type 2 diabetes. The research seeks to address the challenges faced by individuals with type 2 diabetes who struggle with obesity or being overweight. The goal is to determine whether the medication’s efficacy and safety suit these individuals. This study’s result could improve treatment choices and overall well-being for those with type 2 diabetes.

This clinical trial studies the safety and effectiveness of an experimental medication compared to a different drug for people diagnosed with type 2 diabetes. These participants are also either obese or overweight and have an increased risk of cardiovascular issues. The study aims to assess the treatment’s potential benefits and risks.